NewsWhore
02-16-2010, 01:30 PM
Submit your comment AstraZeneca Plc waded into the competitive rheumatoid arthritis market on Tuesday by signing a deal worth up to $1.245 billion (R9.6 billion) for rights to Rigel Pharmaceuticals In...
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/32290199/)
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/32290199/)